rAAV Engineering for Capsid-Protein Enzyme Insertions and Mosaicism Reveals Resilience to Mutational, Structural and Thermal Perturbations.
Rebecca C FeinerJulian TeschnerKathrin E TeschnerMarco T RadukicTobias BaumannSven HagenYvonne HannappelNiklas BiereDario AnselmettiKatja M ArndtKristian M MüllerPublished in: International journal of molecular sciences (2019)
Recombinant adeno-associated viruses (rAAV) provide outstanding options for customization and superior capabilities for gene therapy. To access their full potential, facile genetic manipulation is pivotal, including capsid loop modifications. Therefore, we assessed capsid tolerance to modifications of the structural VP proteins in terms of stability and plasticity. Flexible glycine-serine linkers of increasing sizes were, at the genetic level, introduced into the 587 loop region of the VP proteins of serotype 2, the best studied AAV representative. Analyses of biological function and thermal stability with respect to genome release of viral particles revealed structural plasticity. In addition, insertion of the 29 kDa enzyme β-lactamase into the loop region was tested with a complete or a mosaic modification setting. For the mosaic approach, investigation of VP2 trans expression revealed that a Kozak sequence was required to prevent leaky scanning. Surprisingly, even the full capsid modification with β-lactamase allowed for the assembly of capsids with a concomitant increase in size. Enzyme activity assays revealed lactamase functionality for both rAAV variants, which demonstrates the structural robustness of this platform technology.
Keyphrases
- gene therapy
- escherichia coli
- klebsiella pneumoniae
- multidrug resistant
- single cell
- gram negative
- genome wide
- disease virus
- copy number
- transcription factor
- high resolution
- risk assessment
- cross sectional
- quantum dots
- dna methylation
- dengue virus
- protein kinase
- human health
- social support
- gold nanoparticles
- protein protein
- electron microscopy